Importantly, BTK appears to act as a rheostat and not as an on-off switch, with overexpression leading to autoimmunity while BTK inhibition improves outcomes of autoimmune disorders such as rheumatoid arthritis and multiple sclerosis [40,48,68]. The gene discussed is BTK; the disease is multiple sclerosis.